Using the second drug with bedaquiline
made tuberculosis bacteria more vulnerable, pointing to a potential strategy for dealing with persistent infections.
Not exact matches
In the test tube experiments, SMARt - 420
made ethionamide more potent in both ethionamide sensitive and resistant
bacteria, and it worked against a wide range of M.
tuberculosis strains.
The Dartmouth candidate, DAR - 901, is an inactivated vaccine
made from a non-pathogenic
bacterium that is genetically related to Mycobacterium
tuberculosis, the cause of human
tuberculosis.